Curis Inc (CRIS) Q4 2024 Earnings Call Highlights: Financial Improvements and Promising ...

featured-image

Curis Inc (CRIS) reports reduced net loss and expenses, while advancing its emavusertib program with potential accelerated approvals.

Curis Inc (CRIS) reports reduced net loss and expenses, while advancing its emavusertib program with potential accelerated approvals..